Please login to the form below

Not currently logged in
Email:
Password:

referendum

This page shows the latest referendum news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk invests £115m in Oxford diabetes unit

Novo Nordisk invests £115m in Oxford diabetes unit

AstraZeneca (AZ) is in the midst of setting up a new headquarters and R&D campus in Cambridge, although that project began ahead of the referendum. ... Speaking to the BBC, Novo's chief science officer Mads Thomsen said the EU referendum result had given

Latest news

  • Brexit - a tough pill to swallow Brexit - a tough pill to swallow

    All top ten global pharmaceutical companies operate in the UK. Immediately after the EU referendum result, the value of the pharmaceutical industry increased.

  • Surviving Brexit Surviving Brexit

    It may come as no surprise that a pre-referendum 'Brexit' poll conducted by the UK Pharmaceutical directors Club of senior management within the uK pharmaceutical industry resulted in a vast ... UK Government, industry and other EU and international

  • EMA: ‘business as usual’ - for now - after Brexit EMA: ‘business as usual’ - for now - after Brexit

    EMA would like to underline that its procedures and work streams are not affected by the outcome of the referendum,” it said. “ ... environment generated by the outcome of the UK referendum,” it said in a statement.

  • UK pharma faces 'immediate challenges' following Brexit UK pharma faces 'immediate challenges' following Brexit

    Nevertheless, the referendum's outcome caused shares to plunge and the pound hit a 31-year low as the markets reacted.

  • UK biotech beats fundraising records in 2015, says BIA UK biotech beats fundraising records in 2015, says BIA

    Despite the many positives, the BIA sounds a note of caution as issues such as uncertainty caused by the Brexit referendum later this month and reports of a lack of seed

More from news
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 2)

    Originally pro-Brexit, Woollaston swapped sides before the referendum, and has since become highly critical of the government’s approach to Brexit.

  • Brexit Means Brexit Brexit Means Brexit

    Brexit Means Brexit. The differential destinations of post-Brexit pharma. “Brexit means Brexit.”The three little words that launched Theresa May’s leadership campaign in the aftermath of the EU referendum

  • Brexit implications for UK pharma legislation Brexit implications for UK pharma legislation

    Switzerland only regained full association to Horizon 2020 this year after not implementing EU migrant quotas voted for in a 2014 referendum.

  • Brexit: the facts (and the alternative facts) Brexit: the facts (and the alternative facts)

    Since the ‘Brexit’referendum last June, there has been much confusion and heated debate about what this actually means. ... As Teresa May said, before Brexit and her premiership, “It’s hard to think of an industry of greater strategic importance

  • Brexit: Implications for the pharma industry Brexit: Implications for the pharma industry

    Important points. The referendum is the first step; it’s unlikely there will be any significant change in the UK’s status in the EU prior to the UK leaving the

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics